FDA Inspection 1100868 — Yamil Canaan, M.D.
The FDA completed an inspection of Yamil Canaan, M.D. on August 22, 2019 in Coral Gables, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Coral Gables, FL (United States)
Additional Details
Clinical Investigator (CI)